US Patent

US7329689 — Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester

Composition of Matter · Assigned to Italfarmaco SpA · Expires 2027-01-15 · 1y remaining

Vulnerability score 35/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a compound with formula (I) and a process for its preparation.

USPTO Abstract

A compound having formula (I) and a process for the preparation thereof are described.

Drugs covered by this patent

givinostat-hydrochloride (GIVINOSTAT HYDROCHLORIDE)

Patent Metadata

Patent number: US7329689
Jurisdiction: US
Classification: Composition of Matter
Expires: 2027-01-15
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Italfarmaco SpA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.